International eDelphi Study to Reach Consensus on the Methotrexate Dosing Regimen in Patients With Psoriasis

Astrid M. van Huizen; S.P. Menting; Rolland Gyulai; Lars Iversen; G. E. van der Kraaij; Maritza A. Middelkamp‐Hup; Richard B. Warren; Phyllis I. Spuls; Adrián A. Schejtman; Alexander Egeberg; Alireza Firooz; Alur S. Kumar; Amanda Oakley; Amy Foulkes; Andréa Machado Coelho Ramos; Anne‐Claire Fougerousse; Antoanela Čarija; Ayşe Akman-Karakaş; Barbara Horváth; Béata Fábos; Benjamín Hidalgo Matlock; Birgitta Wilson Claréus; Carla Castro; Carlos Ferrándiz; Carolina Cortés Correa; Carolina Marchesi; C. Goujon; Cèsar Gonzàlez; César Maldonado-García; Chih-ho Hong; Christopher Em Griffiths; Christian Vestergaard; Christina Mariela Echeverría; Claudia de la Cruz; Curdin Conrad; Dániel Törőcsik; Daniela Ledić Drvar; Deepak Balak; D. Jullien; Diebrecht Appelen; Dong Hyun Kim; E.M.G.J. de Jong; Emad El Gamal; Emmanuel Laffitte; E. Mahé; Enikö Sonkoly; Erika Páez Colombo; Eva Vilarrasa; Fabienne Willaert; Farah Novoa; Farhad Handjani; Fernando Valenzuela; Francisco Vílchez‐Márquez; Gabriela Otero González; Krisztián Gáspár; Giovanni Damiani; Gordana Krnjević-Pezić; Graciela Pellerano; G. Carretero; H.J.A. Hunter; Hassan Riad; Hazel H. Oon; Hugo P.J. Boonen; Iftin Osman Moussa; I. García‐Doval; Ildíko Csányi; Ines Brajac; Irina Turchin; Ivan Grozdev; Jeffrey M Weinberg; Jenny Nicolopoulos; Jillian Wells; Jo Lambert; John R Ingram; Jörg C. Prinz; José Alexandre de Souza Sittart; José Luis Alfonso Sánchez; Josephine Pa-Fan Hsiao; Juan Raúl Castro‐Ayarza; Julia‐Tatjana Maul; J.M.P.A. van den Reek; Katarina Trčko; Kirk Barber; Kristian Reich; Kurt Gebauer; Kuzma Кhobzei; Lara Valeska Maul; Larisa Prpić Massari; L. Fardet; Laurence Le Cleach; L. Misery; Laxmisha Chandrashekar; Lidia Irinel Muresanu; L.L.A. Lecluse; Lone Skov; Ma. Lorna F. Frez; Lucija Tomić Babić; L. Puig; Luis Castro Gomez

doi:10.1001/jamadermatol.2022.0434

Abstract

1 min read

In this eDelphi consensus study, consensus was reached on 20 of 21 proposals involving methotrexate dosing in patients with psoriasis. This consensus may potentially be used to harmonize the treatment with methotrexate in patients with psoriasis.

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2000

The use of folic acid supplementation in psoriasis patients receiving methotrexate: a survey in the United Kingdom

Brian Kirby, Calum C. Lyon, Christopher Em Griffiths, R. J. G. Chalmers

Article1999

Combination treatment with methotrexate and cyclosporin for severe recalcitrant psoriasis

Clark, Kirby, M. A. Morris, Davison, Zaki, Emerson, Saihan, Chalmers, Juliet N. Barker, Allen, Christopher Em Griffiths

Article2023

004 Does methotrexate affect treatment persistence or effectiveness of adalimumab for psoriasis? A trial emulation cohort study

Zenas Z N Yiu, Catherine Smith, Philip Laws, Philip Hampton, Christopher Em Griffiths, Richard B. Warren

Article2008

Methotrexate for psoriasis in the era of biological therapy

Richard B. Warren, R.J.G. Chalmers, Christopher Em Griffiths, Alan Menter

Article2010

Definition of treatment goals for moderate to severe psoriasis: a European consensus

Ulrich Mrowietz, Knud Kragballe, Kristian Reich, Phyllis I. Spuls, Christopher Em Griffiths, Alexander Nast, J Franke, C. Antoniou, Petr Arenberger, Flora Balieva, Matilda Bylaitė, Osvaldo Correia, E. Daudén, Paolo Gisondi, Lars Iversen, Lajos Kemény, M. Lahfa, Tamar Nijsten, Tapio Rantanen, Adam Reich, T. Rosenbach, Siegfried Segaert, Catherine Smith, T. Talme,